Bonnie Bassler

Bonnie Bassler

Directeur/Membre du Conseil chez ROYALTY PHARMA PLC

Fortune : 5 M $ au 31/05/2026

63 ans
Commercial Services
Health Technology
Consumer Services

Profil

Bonnie L.
Bassler
is an Independent Director at Regeneron Pharmaceuticals, Inc. since 2016, an Independent Director at Royalty Pharma Plc since 2020, and a Trustee at the Alfred P.
Sloan Foundation since 2014.
Memberships include The Royal Society, National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Medicine (United States), and American Philosophical Society.
Former roles include Chairman of the Governors Board at the American Society for Microbiology from 2011 to 2014, Chairman of the Molecular Biology Department at Princeton University from 2013 to 2025, Independent Director at Sanofi from 2014 to 2016, Independent Director at Cidara Therapeutics, Inc. from 2021 to 2026, Director at the American Association for the Advancement of Science from 2012 to 2016, Director at The National Science Foundation from 2010 to 2016, Independent Director at Kaleido Biosciences, Inc. from 2018 to 2022, Director at the American Academy of Microbiology, Professor at Howard Hughes Medical Institute, Inc., Research Scientist at The Agouron Institute, and Member of The National Science Board from 2010 to 2016.
Education includes a doctorate from The Johns Hopkins University and undergraduate studies at the University of California, Davis.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/06/2026 78 492 ( 0,02 % ) 4 M $ 31/05/2026
14/04/2026 1 616 ( 0 % ) 993 484 $ 31/05/2026

Postes actifs de Bonnie Bassler

SociétésPosteDébut
REGENERON PHARMACEUTICALS, INC. Directeur/Membre du Conseil 12/09/2016
ROYALTY PHARMA PLC Directeur/Membre du Conseil 16/06/2020
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/01/2014
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Bonnie Bassler

SociétésPosteFin
CIDARA THERAPEUTICS Directeur/Membre du Conseil 07/01/2026
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Bonnie Bassler

Formation de Bonnie Bassler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

94

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Health Technology

Health Technology

Commercial Services

Miscellaneous

Consumer Services

Miscellaneous

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

American Academy of Microbiology

Commercial Services

The National Science Board

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Bonnie Bassler
🔇